Henry Schein Stock Price, News & Analysis

Henry Schein, Inc. (NASDAQ: HSIC) announced the retirement of CFO Steven Paladino, effective April 29, 2022, after 35 years with the company. Ronald N. South, currently Vice President of Corporate Finance, will succeed him. Paladino will remain on the Board of Directors and serve as an advisor post-retirement. Under Paladino's leadership, the company experienced significant growth, achieving a compound annual growth rate of approximately 12% in net sales and earnings per share since going public in 1995. The transition aims to ensure continuity in financial management.

Henry Schein, the leading provider of healthcare solutions for dental and medical practitioners, will present virtually at the 40th Annual J.P. Morgan Healthcare Conference on January 12, 2022, at 9:45 a.m. Eastern time. The event will be accessible via live webcast on Henry Schein's investor relations website. As a FORTUNE 500 Company and member of the S&P 500 index, Henry Schein reported sales of $10.1 billion in 2020, with a consistent compound annual growth rate of 12% since going public in 1995. For additional details, visit their website.

Henry Schein, Inc. (Nasdaq: HSIC) announced that CEO Stanley M. Bergman received an award from The National Hispanic Foundation for his efforts in promoting health equity for Hispanic communities. The recognition occurred during the 18th Annual New York Hispanic Health Professional Student Scholarship Gala. Bergman emphasized the company's commitment to reducing health disparities and improving access to healthcare. Over three decades, Henry Schein has partnered with organizations to foster diversity in healthcare and support the recruitment of Hispanic professionals.

Henry Schein (NASDAQ: HSIC) has signed a cooperative contract with OMNIA Partners to enhance procurement access for K-12, higher education, and healthcare sectors. This agreement includes a master contract with the University of California, facilitating medical supply distribution to eligible public agencies. The offerings include point-of-care diagnostic testing, PPE, and various medical products. The contract aims to streamline procurement, increase savings, and improve health services accessibility for students and staff.

Henry Schein (NASDAQ: HSIC) has donated over $100,000 to TeamSmile, a non-profit providing dental care to underserved children. This year alone, the company contributed $30,000 in cash, nearly $40,000 in dental supplies, and $25,000 for practice management software training. Since 2007, donations have reached approximately $1 million. TeamSmile has served over 40,000 children, offering over $17 million in free dental care. The remaining TeamSmile event for 2021 will be held at Mercedes-Benz Stadium in Atlanta, GA.

Henry Schein has appointed Scott Serota, former President and CEO of Blue Cross Blue Shield Association, to its Board of Directors effective immediately. Serota, who expanded BCBSA's membership from 65 million to over 100 million, is expected to contribute his healthcare expertise to advance the company's strategic goals. Meanwhile, Barry Alperin will retire from the Board in May, adhering to the director resignation policy upon reaching 80 years of age. This change aims to bolster leadership and a focus on public health challenges.

Henry Schein Orthodontics has launched Studio Pro™ 4.0, an advanced web-based treatment planning software for Reveal® Clear Aligners. This new platform, integrated with the DDX® Case Management Portal, enables providers to customize treatment plans with over 25 new features, enhancing user experience for practitioners of all skill levels. Phil Prentice, President of Henry Schein’s Orthodontics Group, emphasized the software's role in simplifying workflows. The software aims to improve patient communication and treatment control, marking a significant advancement in orthodontic technology.